Standout Papers
- Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment (2000)
- IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. (1997)
- Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma (1994)
Immediate Impact
3 by Nobel laureates 27 from Science/Nature 70 standout
Citing Papers
Cancer therapy with antibodies
2024 Standout
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
2021 StandoutNature
Works of J. Rosenberg being referenced
Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma
1998
Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma
1994 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| J. Rosenberg | 2140 | 1768 | 1154 | 1211 | 27 | 4.0k | |
| M. S. Czuczman | 3632 | 2272 | 2454 | 1495 | 59 | 5.5k | |
| Michael Wenger | 2013 | 1639 | 1109 | 477 | 70 | 3.4k | |
| A.J. Grillo-López | 4248 | 2663 | 2825 | 2447 | 36 | 6.9k | |
| Christine A. White | 4583 | 2463 | 2787 | 2894 | 33 | 7.0k | |
| Mukesh Chhanabhai | 4681 | 1403 | 2898 | 296 | 48 | 5.5k | |
| P L Duffey | 1617 | 581 | 1073 | 256 | 30 | 2.7k | |
| Éric Van Den Neste | 5335 | 1918 | 4120 | 666 | 45 | 7.0k | |
| Gustaaf W. van Imhoff | 2217 | 946 | 1835 | 220 | 84 | 3.6k | |
| Y Bastion | 2442 | 1175 | 1612 | 176 | 47 | 3.2k | |
| Francesco d’Amore | 4296 | 809 | 2310 | 996 | 171 | 5.6k |
All Works
Loading papers...